secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001193125-25-231963
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Gillian Cannon resigns from Corcept board; consulting agreement signed
-------------------------------------------------------------------------------

- Dr. Gillian Cannon resigned from the Board effective October 10, 2025, with no disagreement over operations or policies.
- Company and Cannon entered consulting agreement from effective date until 2026 annual stockholder meeting.
- Consulting fee: $5,708.33 per month; previously awarded stock options continue vesting per original schedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000119312525231963/0001193125-25-231963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000119312525231963/d817312d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-231963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer